Cedillo, Princess .
HRN: 24-98-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2024
AMPICILLIN 1GM (VIAL)
05/12/2024
05/14/2024
IV
2g
Q6H
PROM X 18 Hours
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes